7 patents
Utility
Dosing of Vibegron for Treatment of Overactive Bladder
13 Jul 23
The present disclosure is directed to a method of treating overactive bladder comprising orally administering to a subject in need thereof an amount of from about 50 mg to about 100 mg (e.g., about 75 mg) of vibegron per day.
Stephen C. PISCITELLI, Paul MUDD
Filed: 24 Oct 22
Utility
Use of Vibegron to Treat Overactive Bladder
26 Jan 23
The present disclosure is directed to a method of treating overactive bladder comprising orally administering to a subject in need thereof an amount of 75 mg of vibegron per day.
Paul N. MUDD, Jr.
Filed: 18 Mar 20
Utility
Compositions and Methods for the Treatment of Smooth Muscle Dysfunction
5 May 22
The present disclosure provides compositions and methods to treat diseases and conditions related to smooth muscle dysfunction, or to ameliorate symptoms thereof comprising gene therapy, wherein one or more polynucleotides encoding one or more subunits of the Maxi-K channel, or mutants, variants, functional fragments, or derivatives thereof (e.g., fusions and chimaeras) are administered to a subject in need thereof, and wherein the administration of the polypeptides result in the expression of functional Maxi-K channels in the targeted smooth muscle.
Arnold MELMAN
Filed: 14 Nov 19
Utility
Vibegron for the Treatment of Overactive Bladder Symptoms
21 Apr 22
The present disclosure is directed to a method of treating overactive bladder symptoms in men with benign prostatic hyperplasia comprising orally administering to a subject in need thereof an amount of from about 60 mg to about 90 mg (e.g., about 75 mg) of vibegron per day.
Paul N. MUDD, Jr., Cornelia HAAG-MOLKENTELLER, Jihao ZHOU
Filed: 5 Dec 19
Utility
Use of Vibegron to Treat Pain Associated with Irritable Bowel Syndrome
1 Jul 21
The present disclosure is directed to a method of treating or preventing pain associated with irritable bowel syndrome comprising orally administering to a subject in need thereof vibegron.
Paul N. MUDD, JR., Cornelia HAAG-MOLKENTELLER, Jihao ZHOU, Chris SCHAUMBURG, Jean Paul Abrian NICANDRO
Filed: 23 May 19
Utility
Use of Vibegron to Treat Overactive Bladder
18 Mar 21
The present disclosure is directed to a method of treating overactive bladder comprising orally administering to a subject in need thereof an amount of from about 60 mg to about 90 mg (e.g., about 75 mg) of vibegron per day.
Stephen C. PISCITELLI, Paul MUDD
Filed: 6 Jun 18
Utility
Dosing of Vibegron for Treatment of Overactive Bladder
18 Mar 21
The present disclosure is directed to a method of treating overactive bladder comprising orally administering to a subject in need thereof an amount of from about 50 mg to about 100 mg (e.g., about 75 mg) of vibegron per day.
Stephen C. PISCITELLI, Paul MUDD
Filed: 6 Jun 18
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first